Cargando…
A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study
Liver cirrhotic patients suffer from a seemingly unpredictable risk of hepatocellular carcinoma (HCC). Here, an HCC risk score R (0 ≦ R ≦ 1) was derived from commonly tested haematological and biochemical parameters. In the score-derivation Taiwanese cohort (144 cirrhosis versus 48 HCC-remission pat...
Autores principales: | Liang, Kung-Hao, Ahn, Sang Hoon, Lee, Hye Wong, Huang, Ya-Hui, Chien, Rong-Nan, Hu, Tsung-Hui, Lin, Kwang-Huei, Yeh, Christopher Sung-Huan, Hsu, Chao-Wei, Lin, Chih-Lang, Pan, Tai-Long, Ke, Po-Yuan, Chang, Ming-Ling, Yeh, Chau-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988718/ https://www.ncbi.nlm.nih.gov/pubmed/29872158 http://dx.doi.org/10.1038/s41598-018-26992-3 |
Ejemplares similares
-
A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients
por: Huang, Ya-Hui, et al.
Publicado: (2017) -
Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients
por: Liang, Kung-Hao, et al.
Publicado: (2021) -
Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
por: Lai, Ming-Wei, et al.
Publicado: (2019) -
Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
por: Liao, Chia-Jung, et al.
Publicado: (2022) -
Mifepristone inhibits hepatoma growth by enhancing the GR-HSP60-survivin interaction to facilitate survivin degradation
por: Huang, Ya-Hui, et al.
Publicado: (2023)